Key facts
- This page summarizes William A. Backus's Form 4 filing for BALCHEM CORP (BCPC).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Aug 2024, 18:09.
William A. Backus - 30 Jul 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)
- Reporting relationship
- VP & Chief Accounting Officer
- Issuer ticker
- BCPC
- Reported as of
- 30 Jul 2024
- Net transaction value
- -$531,609
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2024, 18:09:27 UTC
- Prior SEC filing
- 27 Feb 2024
- Next SEC filing
- 12 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Travis Larsen, Attorney in Fact for William A Backus
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William A. Backus filed Form 4 for BALCHEM CORP (BCPC) on 01 Aug 2024.
Change
- Previous filing in this sequence was filed on 27 Feb 2024.
- Current net transaction value: -$531,609.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BCPC
transaction
Common Stock
Options Exercise
- Transaction value
- $327,951
- Shares
- +3,900
- Change %
- +78%
- Price
- $84.09
- Shares after
- 8,888
- Date
- 30 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
BCPC
transaction
Common Stock
Sale
- Transaction value
- $639,912
- Shares
- -3,570
- Change %
- -40%
- Price
- $179.25
- Shares after
- 5,318
- Date
- 30 Jul 2024
- Ownership
- Direct
- Footnotes
- F2
BCPC
transaction
Common Stock
Sale
- Transaction value
- $59,554
- Shares
- -330
- Change %
- -6.2%
- Price
- $180.47
- Shares after
- 4,988
- Date
- 30 Jul 2024
- Ownership
- Direct
- Footnotes
- F3
BCPC
transaction
Common Stock
Sale
- Transaction value
- $160,094
- Shares
- -904
- Change %
- -87%
- Price
- $177.10
- Shares after
- 132
- Date
- 30 Jul 2024
- Ownership
- 401(k) Plan
- Footnotes
- F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCPC
transaction
Derivative
Stock Options (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,900
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,900
- Exercise price
- $84.09
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Exercise of fully vested non-qualified stock options.
Footnote F2
This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Footnote F3
This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Footnote F4
Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.
Footnote F5
Reflects shares previously acquired under the Balchem Corporation 401(k) plan.
Footnote F6
Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.